Methods and therapeutic combinations for the treatment of xanthoma using sterol absorption inhibitors
First Claim
Patent Images
1. A method of decreasing the incidence of xanthoma in a subject comprising the step of administering to a subject in need of such treatment an effective amount of a combination of (i) at least one sterol absorption inhibitor, at least one 5α
- -stanol absorption inhibitor, or a pharmaceutically acceptable salt or solvate thereof and (ii) at least one HMG-CoA reductase inhibitor as a cholesterol biosynthesis inhibitor, to decrease the incidence of xanthoma in the subject, wherein the at least one sterol or 5α
-stanol absorption inhibitor is represented by Formula (I);
2 Assignments
0 Petitions
Accused Products
Abstract
The present invention provides therapeutic combinations and methods including at least one sterol or 5α-stanol absorption inhibitor that can be useful for treating xanthomas.
-
Citations
2 Claims
-
1. A method of decreasing the incidence of xanthoma in a subject comprising the step of administering to a subject in need of such treatment an effective amount of a combination of (i) at least one sterol absorption inhibitor, at least one 5α
- -stanol absorption inhibitor, or a pharmaceutically acceptable salt or solvate thereof and (ii) at least one HMG-CoA reductase inhibitor as a cholesterol biosynthesis inhibitor, to decrease the incidence of xanthoma in the subject, wherein the at least one sterol or 5α
-stanol absorption inhibitor is represented by Formula (I);
- View Dependent Claims (2)
- -stanol absorption inhibitor, or a pharmaceutically acceptable salt or solvate thereof and (ii) at least one HMG-CoA reductase inhibitor as a cholesterol biosynthesis inhibitor, to decrease the incidence of xanthoma in the subject, wherein the at least one sterol or 5α
Specification